317 related articles for article (PubMed ID: 15689155)
1. Synthesis and biological testing of purine derivatives as potential ATP-competitive kinase inhibitors.
Laufer SA; Domeyer DM; Scior TR; Albrecht W; Hauser DR
J Med Chem; 2005 Feb; 48(3):710-22. PubMed ID: 15689155
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, biological testing, and binding mode prediction of 6,9-diarylpurin-8-ones as p38 MAP kinase inhibitors.
Hauser DR; Scior T; Domeyer DM; Kammerer B; Laufer SA
J Med Chem; 2007 May; 50(9):2060-6. PubMed ID: 17411025
[TBL] [Abstract][Full Text] [Related]
3. Discovery and characterization of non-ATP site inhibitors of the mitogen activated protein (MAP) kinases.
Comess KM; Sun C; Abad-Zapatero C; Goedken ER; Gum RJ; Borhani DW; Argiriadi M; Groebe DR; Jia Y; Clampit JE; Haasch DL; Smith HT; Wang S; Song D; Coen ML; Cloutier TE; Tang H; Cheng X; Quinn C; Liu B; Xin Z; Liu G; Fry EH; Stoll V; Ng TI; Banach D; Marcotte D; Burns DJ; Calderwood DJ; Hajduk PJ
ACS Chem Biol; 2011 Mar; 6(3):234-44. PubMed ID: 21090814
[TBL] [Abstract][Full Text] [Related]
4. Interaction profiles of protein kinase-inhibitor complexes and their application to virtual screening.
Chuaqui C; Deng Z; Singh J
J Med Chem; 2005 Jan; 48(1):121-33. PubMed ID: 15634006
[TBL] [Abstract][Full Text] [Related]
5. Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds.
Dalgarno D; Stehle T; Narula S; Schelling P; van Schravendijk MR; Adams S; Andrade L; Keats J; Ram M; Jin L; Grossman T; MacNeil I; Metcalf C; Shakespeare W; Wang Y; Keenan T; Sundaramoorthi R; Bohacek R; Weigele M; Sawyer T
Chem Biol Drug Des; 2006 Jan; 67(1):46-57. PubMed ID: 16492148
[TBL] [Abstract][Full Text] [Related]
6. Novel synthesis and structural characterization of a high-affinity paramagnetic kinase probe for the identification of non-ATP site binders by nuclear magnetic resonance.
Moy FJ; Lee A; Gavrin LK; Xu ZB; Sievers A; Kieras E; Stochaj W; Mosyak L; McKew J; Tsao DH
J Med Chem; 2010 Feb; 53(3):1238-49. PubMed ID: 20038108
[TBL] [Abstract][Full Text] [Related]
7. Screening of protein kinases by ATP-STD NMR spectroscopy.
McCoy MA; Senior MM; Wyss DF
J Am Chem Soc; 2005 Jun; 127(22):7978-9. PubMed ID: 15926798
[TBL] [Abstract][Full Text] [Related]
8. The design and synthesis of novel alpha-ketoamide-based p38 MAP kinase inhibitors.
Montalban AG; Boman E; Chang CD; Ceide SC; Dahl R; Dalesandro D; Delaet NG; Erb E; Ernst JT; Gibbs A; Kahl J; Kessler L; Lundström J; Miller S; Nakanishi H; Roberts E; Saiah E; Sullivan R; Wang Z; Larson CJ
Bioorg Med Chem Lett; 2008 Mar; 18(6):1772-7. PubMed ID: 18325768
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of trisubstituted imidazole derivatives as inhibitors of p38alpha mitogen-activated protein kinase.
Kim DK; Lim JH; Lee JA; Dewang PM
Bioorg Med Chem Lett; 2008 Jul; 18(14):4006-10. PubMed ID: 18571921
[TBL] [Abstract][Full Text] [Related]
10. Discovery of 4-morpholino-6-aryl-1H-pyrazolo[3,4-d]pyrimidines as highly potent and selective ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR): optimization of the 6-aryl substituent.
Verheijen JC; Richard DJ; Curran K; Kaplan J; Lefever M; Nowak P; Malwitz DJ; Brooijmans N; Toral-Barza L; Zhang WG; Lucas J; Hollander I; Ayral-Kaloustian S; Mansour TS; Yu K; Zask A
J Med Chem; 2009 Dec; 52(24):8010-24. PubMed ID: 19894727
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and biological evaluation of novel Tri- and tetrasubstituted imidazoles as highly potent and specific ATP-mimetic inhibitors of p38 MAP kinase: focus on optimized interactions with the enzyme's surface-exposed front region.
Laufer SA; Hauser DR; Domeyer DM; Kinkel K; Liedtke AJ
J Med Chem; 2008 Jul; 51(14):4122-49. PubMed ID: 18578517
[TBL] [Abstract][Full Text] [Related]
12. New modifications to the area of pyrazole-naphthyl urea based p38 MAP kinase inhibitors that bind to the adenine/ATP site.
Moss N; Breitfelder S; Betageri R; Cirillo PF; Fadra T; Hickey ER; Kirrane T; Kroe RR; Madwed J; Nelson RM; Pargellis CA; Qian KC; Regan J; Swinamer A; Torcellini C
Bioorg Med Chem Lett; 2007 Aug; 17(15):4242-7. PubMed ID: 17560108
[TBL] [Abstract][Full Text] [Related]
13. Inclining the purine base binding plane in protein kinase CK2 by exchanging the flanking side-chains generates a preference for ATP as a cosubstrate.
Yde CW; Ermakova I; Issinger OG; Niefind K
J Mol Biol; 2005 Mar; 347(2):399-414. PubMed ID: 15740749
[TBL] [Abstract][Full Text] [Related]
14. [Progress in the design of selective ATP-competitive kinase inhibitors].
Deng XQ; Xiang ML; Jia R; Yang SY
Yao Xue Xue Bao; 2007 Dec; 42(12):1232-6. PubMed ID: 18338633
[TBL] [Abstract][Full Text] [Related]
15. Novel 8-arylated purines as inhibitors of glycogen synthase kinase.
Ibrahim N; Mouawad L; Legraverend M
Eur J Med Chem; 2010 Aug; 45(8):3389-93. PubMed ID: 20472330
[TBL] [Abstract][Full Text] [Related]
16. Dissection of the recognition properties of p38 MAP kinase. Determination of the binding mode of a new pyridinyl-heterocycle inhibitor family.
Soliva R; Gelpí JL; Almansa C; Virgili M; Orozco M
J Med Chem; 2007 Jan; 50(2):283-93. PubMed ID: 17228870
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of novel disubstituted dibenzosuberones as highly potent and selective inhibitors of p38 mitogen activated protein kinase.
Koeberle SC; Fischer S; Schollmeyer D; Schattel V; Grütter C; Rauh D; Laufer SA
J Med Chem; 2012 Jun; 55(12):5868-77. PubMed ID: 22676210
[TBL] [Abstract][Full Text] [Related]
18. Discovery and optimization of p38 inhibitors via computer-assisted drug design.
Goldberg DR; Hao MH; Qian KC; Swinamer AD; Gao DA; Xiong Z; Sarko C; Berry A; Lord J; Magolda RL; Fadra T; Kroe RR; Kukulka A; Madwed JB; Martin L; Pargellis C; Skow D; Song JJ; Tan Z; Torcellini CA; Zimmitti CS; Yee NK; Moss N
J Med Chem; 2007 Aug; 50(17):4016-26. PubMed ID: 17658737
[TBL] [Abstract][Full Text] [Related]
19. Dibenzosuberones as p38 mitogen-activated protein kinase inhibitors with low ATP competitiveness and outstanding whole blood activity.
Fischer S; Wentsch HK; Mayer-Wrangowski SC; Zimmermann M; Bauer SM; Storch K; Niess R; Koeberle SC; Grütter C; Boeckler FM; Rauh D; Laufer SA
J Med Chem; 2013 Jan; 56(1):241-53. PubMed ID: 23270382
[TBL] [Abstract][Full Text] [Related]
20. Kinase array design, back to front: biaryl amides.
Baldwin I; Bamborough P; Haslam CG; Hunjan SS; Longstaff T; Mooney CJ; Patel S; Quinn J; Somers DO
Bioorg Med Chem Lett; 2008 Oct; 18(19):5285-9. PubMed ID: 18789685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
